Rising Hypertensive Disorders of Pregnancy Across a Statewide Birth Cohort
Hypertensive disorders of pregnancy HDP climbed across nearly every subtype in a large Wisconsin birth cohort, and the increase was not evenly distributed. Among 388,250 pregnancies from 2017 through 2023, the incidence of almost all HDP subtypes rose over time, with severe pre-eclampsia showing the steepest growth. Its average annual percent change reached 11.8% with a 95% confidence interval of 10.6% to 13.0%, a pattern that signals more pregnancies entering the dangerous end of the hypertensive spectrum rather than simply a stable burden shifting by chance.
The findings matter because HDP is not a single diagnosis. It spans chronic hypertension, gestational hypertension, pre-eclampsia, and severe forms that can drive end-organ injury, placental dysfunction, hemorrhage, stroke, and ICU-level maternal illness. Rising incidence across these categories suggests that obstetric teams are facing a larger at-risk population before delivery even begins. In practical terms, more pregnancies now arrive with vascular instability already in motion.
Severe Pre-Eclampsia Rose Fastest While Urban Burden Stayed Highest
Urban areas carried the highest absolute incidence of HDP, but rural counties showed a steeper rise in pre-eclampsia over time. The average annual percent change for pre-eclampsia in rural areas was 8.7% (95% CI, 7.1% to 10.3%), and the difference across geography was statistically significant (p = 0.004). Urban residence therefore reflected a heavier baseline burden, while rural residence reflected faster acceleration.
Those two patterns can coexist for a reason rooted in obstetric care delivery. Urban areas tend to concentrate higher-risk pregnancies, larger referral centers, and more complete ascertainment, which can raise the measured incidence. Rural areas, by contrast, may face different prenatal access patterns, later recognition of blood pressure changes, and more fragmented follow-up. When hypertensive disease develops later in pregnancy and surveillance is less continuous, the disease can progress into severe forms before intervention becomes possible.
The steep increase in severe pre-eclampsia deserves special attention. Severe disease is where placental ischemia, endothelial dysfunction, vasospasm, and multisystem injury converge. A rising incidence in that category implies a growing share of pregnancies with a biological trajectory that is more likely to culminate in urgent delivery, transfusion, seizures, or organ failure.
Black Patients Experienced Higher Incidence and Divergent Trends
Black patients experienced higher incidences of HDP across the cohort, with significant differences in average annual percent change for overall HDP, chronic hypertension, and severe pre-eclampsia. The abstract does not provide the exact p values beyond noting significance for those comparisons, but the direction is unambiguous: the burden was not distributed equally.
This pattern fits a broader maternal health reality. Chronic hypertension often enters pregnancy already established, and it is a major substrate for superimposed pre-eclampsia and other severe complications. Higher baseline rates of chronic hypertension among Black patients can translate into more complicated pregnancies, but biology alone does not explain the full story. Differential access to timely prenatal care, disparities in blood pressure treatment before conception, structural barriers to longitudinal care, and delayed escalation when warning signs appear all shape who develops severe disease and who reaches the hospital too late for prevention.
The statistical differences in trend are especially concerning because they suggest widening rather than narrowing gaps. When the slope rises faster in one group, the cumulative gap grows even if the entire population is trending upward.
HDP and Severe Maternal Morbidity Moved Together
The study also examined severe maternal morbidity SMM in relation to HDP, linking the hypertensive syndromes to a broader maternal safety signal. SMM is the clinical downstream of conditions such as hemorrhage, intensive care admission, acute renal injury, stroke, and other life-threatening complications. When HDP rises, SMM rarely stays flat for long, because hypertensive pregnancy disorders are mechanistically tied to vascular injury and placental disease.
The association between HDP and SMM is biologically plausible and clinically familiar. Hypertension in pregnancy can destabilize the maternal endothelium, impair uteroplacental perfusion, and trigger cascade effects across the kidneys, liver, brain, and hematologic system. Severe pre-eclampsia, in particular, is not just elevated blood pressure with proteinuria; it is a systemic disease that can change in hours. A state-level increase in these diagnoses therefore has implications well beyond the labor unit.
For bedside clinicians, the combination of rising HDP incidence and persistent demographic disparities argues for earlier risk identification, more aggressive blood pressure surveillance, and tighter postpartum follow-up. Pregnancy-related hypertension frequently peaks or worsens after delivery, when patients may no longer be under direct obstetric observation. Missed postpartum blood pressure checks can convert a manageable condition into a readmission or a catastrophic event.
What the Wisconsin Cohort Says About Prevention Pressure
Several features of this statewide analysis strengthen its public health relevance. The cohort was large, spanning more than 388,000 pregnancies over seven years, and the data came from Wisconsin Hospital Association records, allowing trend analysis across geography and demographic strata. Poisson regression was used to estimate incidence rates per 10,000 births and average annual percent changes, which is appropriate for assessing temporal shifts in relatively infrequent obstetric outcomes.
Still, the study also points to the limits of administrative data. ICD-10 coding can misclassify subtypes, and the abstract does not describe all clinical covariates, prenatal care patterns, or postpartum outcomes. Even so, the direction of the findings is hard to ignore: hypertensive pregnancy disorders increased, severe forms increased fastest, rural pre-eclampsia accelerated more quickly than expected, and Black patients bore a higher burden across multiple measures.
The next clinical question is not whether hypertensive disorders of pregnancy matter; they clearly do. The question is how quickly health systems can convert surveillance into prevention, particularly in communities where the disease is rising fastest and where severe maternal morbidity remains linked to gaps in access, continuity, and timely treatment.